Alonzo González-González

5PUBLICATIONS
20CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 04, 2025
In Silico and In Vitro Identification of New Eugenol Derivatives as Inhibitors of the Spike SARS-CoV-2 Protein Interaction With the ACE2 Host Receptor.

Timoteo Delgado-Maldonado, Alonzo González-González, Adriana Moreno-Rodríguez

|Aug 29, 2024
Molecular Docking-Based Virtual Screening of FDA-Approved Drugs Using Trypanothione Reductase Identified New Trypanocidal Agents.

Rogelio Gómez-Escobedo, Domingo Méndez-Álvarez, Citlali Vázquez

|Aug 16, 2024
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives as potential antitubercular agents.

Alonzo González-González, Oscar Sánchez-Sánchez, Baojie Wan

|May 25, 2024
Ligand- and Structure-Based Virtual Screening Identifies New Inhibitors of the Interaction of the SARS-CoV-2 Spike Protein with the ACE2 Host Receptor.

Timoteo Delgado-Maldonado, Alonzo González-González, Adriana Moreno-Rodríguez

|Nov 11, 2022
In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-N-oxide Derivatives against Trypanosoma cruzi as Trypanothione Reductase Inhibitors.

Alonzo González-González, Oscar Sánchez-Sánchez, R Luise Krauth-Siegel

Pageof 1

Frequent Collaborators

5 joint publications

Gildardo Rivera

3 joint publications

Adriana Moreno-Rodríguez

2 joint publications

Emma Saavedra

2 joint publications

José Carlos Espinoza-Hicks